Search

Author/Creator Huang, Moses

1. Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add‐on mirabegron therapy to solifenacin (BESIDE). Issue 5 (16th April 2017)

Authors:
Drake, Marcus J.; MacDiarmid, Scott; Chapple, Christopher R.; Esen, Adil; Athanasiou, Stavros; Cambronero Santos, Javier; Mitcheson, David; Herschorn, Sender; Siddiqui, Emad; Huang, Moses; Stoelzel, Matthias
Journal:
International journal of clinical practice
Issue:
Volume 71:Issue 5(2017)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Efficacy and safety of daily mirabegron 50 mg in male patients with overactive bladder: a critical analysis of five phase III studies. (June 2017)

Authors:
Tubaro, Andrea; Batista, José E.; Nitti, Victor W.; Herschorn, Sender; Chapple, Christopher R.; Blauwet, Mary Beth; Siddiqui, Emad; Huang, Moses; Oelke, Matthias
Journal:
Therapeutic advances in urology
Issue:
Volume 9:Number 6(2017:Jun.)
Page Start:
137
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Mirabegron 50 mg once‐daily for the treatment of symptoms of overactive bladder: An overview of efficacy and tolerability over 12 weeks and 1 year. (4th August 2014)

Authors:
Chapple, Christopher R; Kaplan, Steven A; Mitcheson, David; Blauwet, Mary Beth; Huang, Moses; Siddiqui, Emad; Khullar, Vik
Journal:
International journal of urology
Issue:
Volume 21:Number 10(2014)
Page Start:
960
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Mirabegron improves quality-of-life, treatment satisfaction, and persistence in patients with overactive bladder: a multi-center, non-interventional, real-world, 12-month study. (4th May 2018)

Authors:
Freeman, Robert; Foley, Steve; Rosa Arias, José; Vicente, Eduardo; Grill, Robert; Kachlirova, Zuzana; Stari, Anny; Huang, Moses; Choudhury, Nurul
Journal:
Current medical research and opinion
Issue:
Volume 34:Number 5(2018)
Page Start:
785
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. The efficacy and safety of mirabegron compared with solifenacin in overactive bladder patients dissatisfied with previous antimuscarinic treatment due to lack of efficacy: results of a noninferiority, randomized, phase IIIb trial. (August 2015)

Authors:
Batista, Jose E.; Kölbl, Heinz; Herschorn, Sender; Rechberger, Tomasz; Cambronero, Javier; Halaska, Michael; Coppell, Alex; Kaper, Mathilde; Huang, Moses; Siddiqui, Emad
Journal:
Therapeutic advances in urology
Issue:
Volume 7:Number 4(2015:Aug.)
Page Start:
167
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗